Chemotherapy-induced Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Chemotherapy-induced Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of hetrombopag to prevent chemotherapy-induced thrombocytopenia in patients with…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Single Arm Romiplostim to Prevent CIT [EARLY_Phase 1]
A single-arm Phase 1 trial is evaluating romiplostim to prevent chemotherapy-induced thrombocytopenia in patients with Ewing sarcoma.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Avatrombopag vs. Placebo for CIT in GI Malignancies [Phase 2]
Phase 2 clinical trial comparing avatrombopag to placebo for chemotherapy-induced thrombocytopenia in gastrointestinal cancers; the study is…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Clinical Study on the Efficacy and Safety of Hetrombopag in the Treatment of Thrombocytopenia Induced by Gynecological Tumor Therapy [Phase 2]
Phase 2 clinical trial update investigating hetrombopag for chemotherapy-induced thrombocytopenia caused by gynecological tumor therapy; not…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: TPO Combined With TPORA for Solid Tumors Effectiveness of cTit Above Degree II
This clinical trial is evaluating whether combining thrombopoietin (TPO) with TPORA can improve outcomes for patients with chemotherapy-indu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia [Phase 3]
Phase 3 clinical trial to evaluate the efficacy and safety of hetrombopag olamine tablets versus placebo in patients with chemotherapy-induc…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 clinical study is evaluating hetrombopag for preventing chemotherapy-induced thrombocytopenia in nasopharyngeal carcinoma patients…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study [Phase 2]
Phase 2 exploratory trial evaluating hetrombopag to prevent chemotherapy-induced thrombocytopenia in breast cancer patients, conducted in du…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors [NA]
This clinical trials entry describes a multicenter, open-label randomized study evaluating Romiplostim N01 for chemotherapy- or chemoradioth…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: A Clinical Trial Evaluating SCB-219M in in Chemotherapy-induced Thrombocytopenia (CIT) [Phase 1]
A Phase 1 clinical trial evaluating SCB-219M for chemotherapy-induced thrombocytopenia is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Romiplostim N01 for Chemotherapy-induced Thrombocytopenia [Phase 2]
A Phase 2 clinical trial in China is recruiting to evaluate Romiplostim N01 for chemotherapy-induced thrombocytopenia.
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients [Phase 2]
Phase 2 clinical trial update on Romiplostim (N01) for chemotherapy-induced thrombocytopenia in pediatric cancer patients; the study is curr…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Herombopag for Chemotherapy-induced Thrombocytopenia [Phase 2]
A Phase 2 clinical trial is recruiting in China to evaluate Herombopag for chemotherapy-induced thrombocytopenia.
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Avatrombopag for Chemotherapy-induced Thrombocytopenia [Phase 2]
Phase 2 clinical trial evaluating avatrombopag for chemotherapy-induced thrombocytopenia is currently recruiting in China.
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: A Multicenter Randomized Controlled Study on the Treatment of Refractory CTIT With Romiplostim N01 Compared to Recombinant Human Thrombopoietin [Phase 3]
A Phase 3 randomized trial comparing Romiplostim N01 to recombinant human thrombopoietin for refractory chemotherapy-induced thrombocytopeni…
-
CLINICAL_TRIALS research · 2017-10-18Clinical Trial Update: Protocol for the Infusion of Buffy Coat-derived Cryopreserved Platelets in Patients With Severe Thrombocytopenia [Phase 4]
This entry describes a Phase 4 protocol for infusing Buffy Coat-derived cryopreserved platelets to treat severe thrombocytopenia; the trial …
-
CLINICAL_TRIALS research · 2017-02-10Clinical Trial Update: A Study of the Recombinant Human Interleukin-11 (I) (Baijieyi) for Prevention and Treatment of Chemotherapy-induced Thrombocytopenia in Patients With Malignant Tumor
Clinical trial update on recombinant human interleukin-11 (Baijieyi) for prevention and treatment of chemotherapy-induced thrombocytopenia i…